gary, H.C. Wainwright has a 9 and Roth has an 8; that's where they get 8.50. fyi.
It's all in the numbers. Three done and we haven't heard a word about the second and third. Second cohort to start/or has started. And remember what (I think it was him) Doug Brough said: "We've also demonstrated morphological recovery of sensory cells in human explant models."
It's just a matter of time.
Sentiment: Strong Buy
Sure. It's stuck because we only know of Rob Gerk who was dosed at the U. of Kansas Hospital by Dr. Hinrich Staeker. He hinted that his balance was better, but he could not hear better. It was at the lowest dosage. Stock went up when the sensationalism of potentially restoring hearing was reported, including TV news--google and you can find it--then settled down. We've had no further news. Novartis has now--or is about to--increase the dosage. Here's hoping!
People in the first and second cohorts--let's suppose--want their hearing back but the dosage isn't enough.
Shouldn't they, if the third cohort works, get increased dosage so they can hear? Or do the first gutsy group, stay deaf? It troubles me.
Front page of the New York Times, Sunday, says he's losing his hearing. T'would be a feather in our cap if he was in the second or third cohort and could regain his hearing.
zoos7, got a source on NSCs who went to the same school as Aboody (source is a he) I'll find out what he thinks. Like the fact that they've "oned" in humans and don't have to combine Genvec's delivery with TBX02 in animals. time is money.
Patience, bio. We're now in the king of : cancer, delivering a tumor specific metabolite, SN-38, that is a thousand times more toxic to tumors than what's available. if you are calm, cool, collected, and a long term investor, I'm low on my hundred dollar target...
your anger is understandable. China's lack of economic recovery is a killer. No one thought it would last this long, and shows no sign of ending. things will stink till then.
A company with 31 U.S. patents, 26 more U.S. patents pending, and they just got one, can not be a scam. Read the March 31, 20 F. They might have been financially clumsy in the past, and--who knows--they may still be, but they are legitimate.